A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
Highlands Ranch Hospital
University of Colorado Hospital
Principal Investigator
![Photograph of Elaine Lam](https://som.ucdenver.edu/FIMS/Content/faculty/918/CU-Doctors-918.jpg)
Elaine Lam
Study ID
Protocol Number: 23-1122
More information available at ClinicalTrials.gov: NCT05678673
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers